article thumbnail

European Society of Cardiology Core Curriculum for cardio?oncology

European Journal of Heart Failure

Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.

article thumbnail

NYU Langone taps system director of cardio-oncology

Becker's Hospital Review - Cardiology

NYU Langone Health in New York City has appointed Michelle Bloom, MD, as system director of its cardio-oncology program, effective Dec.

article thumbnail

Sleep Apnea Prevalence in Cardio-Oncology Patients Similar to Other Risk Factors

HCPLive

and sleep apnea prevalence in cardio-oncology patients was the same or greater than other traditional risk factors. Sleep apnea prevalence in cardiology patients was similar to the rates in patients with heart failure.,

article thumbnail

Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer

Frontiers in Cardiovascular Medicine

Cangrelor, a potent intravenous P2Y12 platelet inhibitor, has demonstrated effectiveness in reducing ischemic events without a corresponding increase in severe bleeding during percutaneous coronary intervention, as evidenced by the CHAMPION-PHOENIX trial.

article thumbnail

Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower

DAIC

The emerging field of cardio-oncology is paving the way for expert, multidisciplinary heart care before, during and after cancer treatment to mitigate adverse effects on cardiovascular health.

Cancer 94
article thumbnail

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient”

DAIC

After two full days covering a wide range of issues and experts, the final day will include a joint session with the American College of Cardiology ( ACC ) and the American Society of Clinical Oncology ( ASCO ). Cardio-Oncology Educational Training: What Do I Need to Learn? How to Structure?:

article thumbnail

Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain

Frontiers in Cardiovascular Medicine

The baseline risk of CTRCD was graded according to the risk score proposed by the Heart Failure Association (HFA) Cardio-Oncology Working Group and the International Cardio-Oncology Society (ICOS). CTRCD and its severity were defined according to the current European Society of Cardiology (ESC) guidelines.